Yesterday, when Joe Biden visited Kenosha, Wisconsin — after condemning President Trump’s visit — a video of Biden shows a dark bruise with a needle puncture mark on his left hand.
Here’s the video (h/t @Q_Stewardess):
And here’s a screenshot I took from the video (I circled the bruise in yellow):
Tweeters who are nurses and other medical professionals all identified Biden’s bruise and needle mark as the bruising from an IV (intravenous) drip, elderly people’s skin being thin and easily bruised. Joe Biden will be 78 years old on November 20.
Tweeter @MAGABruno1917 alerts us to the fact that there is an experimental drug called aducanomab that is delivered via monthly IV infusions to reduce cognitive decline in patients with early Alzheimer’s, the most common form of senile dementia.
Aducanumab is a human monoclonal antibody that has been studied for the treatment of Alzheimer’s disease (AD). It was developed by Biogen Inc., which licensed the drug candidate from Neurimmune, its discoverer. The antibody targets aggregated forms of β-amyloid found in the brains of people with Alzheimer’s disease, in the hopes of reducing its buildup. […]
A Phase Ib study was published in August 2016, based on one year of “monthly intravenous infusions” of aducanumab, with brain scans to measure amyloid plaques. Phase 3 clinical trials were ongoing in September 2016, but were canceled in March 2019 after “an independent group’s analysis show[ed] that the trials were unlikely to ‘meet their primary endpoint.’”
Demonrats’ typical tactic is to deflect from their problems by going on the offense.
Unlike Joe Biden, President Trump is lucid and shows no sign of cognitive impairment from strokes or senile dementia. On the contrary, he has the energy of a man half his age.
- DC pharmacy delivers Alzheimer’s drugs to Congress
- Joe Biden confuses his wife with his sister
- Biden utters gibberish, but Left writer will vote for him even if he boils and eats babies
- Why they want to keep Joe Biden out of a debate with President Trump